Indoco Remedies Ltd
BSE:532612
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Indoco Remedies Ltd
BSE:532612
|
IN |
|
A
|
AeroVironment Inc
XBER:JPX
|
US |
|
A
|
Antofagasta PLC
F:FG1
|
UK |
|
K
|
KDDI Corp
DUS:DIP
|
JP |
|
BAE Systems PLC
LSE:BA
|
UK |
|
Grupo Aeroportuario del Sureste SAB de CV
OTC:ASRMF
|
MX |
|
H
|
HubSpot Inc
F:096
|
US |
|
Customers Bancorp Inc
F:334
|
US |
|
Cigna Corp
NYSE:CI
|
US |
|
J
|
Jervois Global Ltd
F:IHS
|
AU |
|
Microstrategy Inc
NASDAQ:MSTR
|
US |
|
Ypsomed Holding AG
LSE:0QLQ
|
CH |
|
B
|
Brambles Ltd
F:R1H
|
AU |
|
FirstEnergy Corp
NYSE:FE
|
US |
|
P
|
Packaging Corp of America
F:PKA
|
US |
Wall St Price Targets
INDOCO Price Targets Summary
Indoco Remedies Ltd
According to Wall Street analysts, the average 1-year price target for INDOCO is 262.96 INR with a low forecast of 225.5 INR and a high forecast of 290.4 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is INDOCO's stock price target?
Price Target
262.96
INR
According to Wall Street analysts, the average 1-year price target for INDOCO is 262.96 INR with a low forecast of 225.5 INR and a high forecast of 290.4 INR.
What is the Revenue forecast for Indoco Remedies Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 13%.
What is the Gross Profit forecast for Indoco Remedies Ltd?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 15%.
